Simplify Logo

Full-Time

VP/SVP – Deputy General Counsel

Confirmed live in the last 24 hours

BridgeBio

BridgeBio

501-1,000 employees

Develops medicines for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$330k - $460kAnnually

+ Performance Bonus + Equity

Expert

San Francisco, CA, USA

Hybrid position requiring in-office presence.

Category
Legal
Risk & Compliance
Legal & Compliance
Requirements
  • Successful completion of a Juris Doctor degree from an accredited law school
  • Active membership in good standing with the bar association of the state where practicing
  • Minimum of 20 years of legal experience, with significant in-house legal experience in the biotech or pharmaceutical industry
  • Proven track record in a senior legal role, preferably within a global organization
  • Excellent interpersonal, written, and verbal communication skills; articulate, direct, and forthright; ability to communicate with all levels of management and leadership; collaborative and decisive team member as well as a strategic thinker with a broad perspective
  • Excellent analytical, problem-solving, and decision-making skills; must be able to exercise sound judgment and provide practical, risk-informed, and constructive legal advice in a fast-paced and complex global environment
  • Ability to align legal strategies with business objectives, contributing to the company's growth and success, and ability to work collaboratively and cross-functionally with internal teams, external advisors, and stakeholders
  • Meticulous attention to detail and a commitment to accuracy in legal research, documentation, and compliance
  • Agility to adapt to changing legal and regulatory landscapes while remaining current with industry trends and best practices; time management and organizational skills necessary to independently manage many matters, appropriately prioritize workload, and plan for resources to meet deadlines and goals; superior ability to work effectively in a fast-paced, dynamic environment
  • Demonstrated ability to lead and develop a high-performing legal team
Responsibilities
  • Assist the CLO in developing and implementing the company's legal strategy
  • Assist the CLO by leading department-wide initiatives designed to foster a culture of excellence, collaboration, and continuous improvement
  • Support CLO in advising the Board of Directors and executive leadership on corporate governance matters
  • Support CLO with corporate secretary function, including preparing materials and minutes for board and committee meetings, and ensuring Company's corporate governance policies and practices meet high standards and comply with relevant regulations
  • Lead experienced Corporate Law team and oversee various matters, including corporate finance (e.g., equity offerings and convertible debt offerings), credit agreements, contract interpretation, M&A, due diligence, joint ventures and collaborations, and other strategic alliance transactions
  • Oversee the drafting, reviewing, and negotiating of a wide range of contracts, including clinical trial agreements, licensing agreements, partnership agreements, and vendor contracts
  • Assist in developing and maintaining training, policies, and procedures to ensure the Company’s compliance with key agreements and international, federal, state, and local laws and regulations (e.g., Sarbanes-Oxley, SEC regulations, NASDAQ regulations)
  • Supervise and ensure compliant preparation of public company securities filings, such as Section 16 filings, Form 8-K, and Form S-8, as well as the proxy statement and annual shareholder meeting materials
  • Work closely with Finance in preparing financial, non-financial and regulatory reporting obligations, such as Form 10-K and Form 10-Q
  • Advise senior management on the legal requirements and implications of securities matters
  • Support Investor Relations in connection with investor calls and conferences, managing the transfer agent relationship and investor outreach
  • Review press releases and public statements for Corporate Communications
  • Advise on compensation and benefits matters, including equity incentive plans, employee stock purchase plans, 401(k) plans, tax and executive compensation
  • Assist Stock Administration with equity plan activities and analysis and stock issuance
  • Provide counsel and advice to senior management on relevant legal and regulatory issues impacting the Company
  • Monitor changes in legislation and regulatory environments globally, assessing their impact on the company's operations
  • Develop and implement policies and procedures to ensure compliance, mitigate legal risks, and manage legal operations
  • Identify and evaluate legal risks to the Company and develop strategies to mitigate these risks
  • Help develop and deliver training programs for employees on legal and compliance matters
  • Promote a culture of ethical behavior and legal compliance throughout the organization

BridgeBio Pharma develops medicines specifically for genetic diseases, focusing on conditions with well-understood genetic causes. The company operates using a decentralized subsidiary model, where each subsidiary concentrates on creating therapies for particular diseases while sharing central resources. This structure enhances efficiency and allows for the simultaneous advancement of multiple drug programs. BridgeBio utilizes advancements in genome sequencing and molecular biology to identify and develop effective treatments. Unlike many competitors, BridgeBio emphasizes independent thinking and transparency, enabling rapid, data-driven decision-making. The company's goal is to create significant therapeutic advancements by targeting diseases at their genetic source, ultimately bringing effective treatments to market more quickly.

Company Stage

IPO

Total Funding

$6.8B

Headquarters

Palo Alto, California

Founded

2014

Growth & Insights
Headcount

6 month growth

24%

1 year growth

65%

2 year growth

88%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments, such as the $46.84 million from Norges Bank and $200 million for the oncology spinout, indicate strong financial backing and growth potential.
  • The launch of BridgeBio Oncology Therapeutics with $200 million in funding highlights the company's commitment to advancing cancer treatments, particularly KRAS inhibitors.
  • Equity grants to new employees under the Amended and Restated 2019 Inducement Equity Plan demonstrate BridgeBio's commitment to attracting and retaining top talent.

What critics are saying

  • The competitive landscape in genetic disease therapies and oncology is intense, with numerous companies vying for market share.
  • The decentralized subsidiary model, while efficient, may lead to challenges in maintaining cohesive strategic direction and operational alignment.

What makes BridgeBio unique

  • BridgeBio's decentralized subsidiary model allows for focused and efficient drug development across multiple genetic diseases simultaneously, unlike traditional centralized biopharma companies.
  • The company's emphasis on genetic diseases with well-understood causes enables targeted and potentially more effective therapies, setting it apart from competitors with broader, less focused pipelines.
  • BridgeBio's robust pipeline of over 15 drug programs targeting 20 different genetic diseases showcases its diversified approach, reducing the traditional biopharma process timeline.

Help us improve and share your feedback! Did you find this helpful?